This program is designed to assist health care providers improve their pulmonary disease education knowledge and skill in an effort to improve long-term pulmonary disease care and improve patient quality of life. At the conclusion of this program, the participant will be able to identify key components of pulmonary disease education and apply their knowledge to the education and management of patients with COPD, asthma, pulmonary fibrosis, cystic fibrosis, lung cancer, and pulmonary hypertension.
Criteria for successful completion includes viewing all course videos in their entirety as well as scoring 70% or higher on the post-course test.
This course is approved by the AARC for 14.5 CRCE.
This course is approved by the Ohio Nurses Association through 12/8/2018. (ONA #20423) The Ohio Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
The AARC produced this educational course with support from the following organizations:
- Pathophysiology and Assessment of COPD: Explain the pathophysiology of COPD; describe the methods of COPD diagnosis; identify treatment strategies for COPD; and describe components of assessment for a patient with COPD
- Pathophysiology and Assessment of Asthma: Explain the pathophysiology of asthma; describe the methods of asthma diagnosis; identify treatment strategies for asthma; and describe components of assessment for a patient with asthma
- Pathophysiology and Assessment of Cystic Fibrosis: Explain the pathophysiology of cystic fibrosis; describe the methods of cystic fibrosis diagnosis; identify treatment strategies for cystic fibrosis; and describe components of assessment for a patient with cystic fibrosis
- Pathophysiology and Assessment of Lung Cancer: Explain the pathophysiology of lung cancer; describe the methods of lung cancer diagnosis; identify treatment strategies for lung cancer; and describe components of assessment for a patient with lung cancer
- Pathophysiology and Assessment of Interstitial Lung Disease: Explain the pathophysiology of interstitial lung disease; describe the methods of interstitial lung disease; identify treatment strategies for interstitial lung disease; and describe components of assessment for a patient with interstitial lung disease
- Pathophysiology and Assessment of Pulmonary Hypertension: Explain the pathophysiology of pulmonary hypertension; describe the methods of pulmonary hypertension diagnosis; identify treatment strategies for pulmonary hypertension; and describe components of assessment for a patient with pulmonary hypertension
- Overview of Disease Management: Identify the key components to a comprehensive disease management program; describe the importance of and the barriers to patient self-management; and identify the skills necessary to be an effective disease manager
- Pulmonary Function Testing: Define three types of pulmonary function tests; review reference equations/predicted values/lower limits of normal; describe quality testing criteria; describe and review lung volumes and capacities; identify specific pulmonary abnormalities with pulmonary function tests; and identify disease severity with pulmonary function tests
- Pharmacologic Interventions: List currently available pulmonary medications; describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes; and determine appropriate delivery method for inhaled medications based on patient cognition, physical ability, and preference
- Supplemental Oxygen Administration: Describe the physiological benefit of supplemental oxygen; differentiate between various home oxygen delivery systems; anddetermine appropriate delivery system to meet patient need
- Tobacco Cessation: Explain the scientific factors supporting tobacco cessation; identify general approaches to smoking cessation; explain the pharmacologic agents employed in a tobacco cessation program; identify the barriers to tobacco cessation; describe motivational interviewing; and demonstrate effective motivational interviewing skills.
- Exacerbation Management: Identify respiratory changes that indicate the presence of a pulmonary disease exacerbation; recognize the severity level of an exacerbation; and determine appropriate interventions for various severity levels of exacerbations
- Nutrition for the Patient with Pulmonary Disease: Describe the measurement of malnutrition; describe the effects of malnutrition on patients with pulmonary disease; and develop a nutrition strategy for patients with pulmonary disease
- Lung Transplantation: Identify the qualifying measures for listing a patient for lung transplantation; discuss the self-management behaviors necessary for maintaining status on the transplantation list; discuss the challenges in adhering to a pre-lung transplantation program; identify the health behaviors necessary for wellness post-transplantation; and discuss the role of the health care provider in assisting the patient post-transplant
- Palliative Care and Chronic Pulmonary Disease: Differentiate between palliative care and hospice; identify appropriate timing to initiate hospice; and discuss palliative care in the context of chronic lung disease
- Pulmonary Rehabilitation: Define pulmonary rehabilitation; describe the essential components of a comprehensive pulmonary rehabilitation program; and explain the benefits of pulmonary rehabilitation
- Discharge Planning: Name the 5 key standards in the Discharge Planning Hospital Conditions of Participation; describe one or two elements of each standard; name the Medicare requirements for reimbursement of commonly ordered respiratory DME; and describe key roles in improving transitions.
- Patient Education: Identify essential components of effective communication and patient education; describe basic adult learning theory; identify barriers to learning; discuss issues with transitional care
- Measurable Outcomes in a Chronic Pulmonary Disease Management Program: Discuss the importance of measuring outcomes to the success of the chronic disease management program; identify meaningful outcomes measures; and discuss reimbursement